Title and 1 Information on how unit were allocated to interventions
Jõ
Delivery method: how was the content given?
Unit of delivery: how were the subjects grouped during delivery? V • How sample size was determined and, when applicable, explanation of any J~) interim analyses and stopping rules Assignment 8
• Unit of assignment (the unit being assigned to study condition, e.g.,
• Method used to assign units to study conditions, including details of any Af/t restriction (e.g., blocking, stratification, minimization) -
• Inclusion of aspects employed to help minimize potential bias induced due \I~\ to non-randomization (e.g., matching)
• Whether or not participants, those administering the interventions, and (masking) those assessing the outcomes were blinded to study condition assignment; AllA if so, statement regarding how the blinding was accomplished and how it was assessed.
Unit of Analysis

10
• Description of the smallest unit that is being analyzed to assess ;.;I/t intervention effects (e.g., individual, group, or community)
--
• If the unit of analysis differs from the unit of assignment, the analytical method used to account for this (e.g., adjusting the standard error WlA estimates by the design effect or using multilevel analysis) Statistica I
11
• Statistical methods used to compare study groups for primary methods V . .11.~).
I"""' assigned to each study condition and the number of participants
Follow-up: the number of participants who completed the follow-~~ũ p or did not complete the follow-up (i.e., lost to follow-up), by ..
--1---1------
• Inclusion of results from testing pre-specified causal pathways through
IJ/Ir
which the intervention was intended to operate, if any Ancillary 18
• Summary of other analyses performed, including subgroup or restricted Vã nalyses analyses, indicating which are pre-specified or exploratory Adverse events 19
• Summary of all important adverse events or unintended effe cts in each study condition (including summary measures, effect size estimates, and
confidence intervals)
DISCUSSION
Interpretation 20
• Interpretation of the results, taking into account study hypotheses, • Discussion of research, programmatic, or policy implications V rf2;.-;"
"' -Generalizability 21
• Generalizability (external validity) ofthe trial findings, taking into account the study population, the characteristics of the intervention, length ofṼ tJ.h.v-f ollow-up, incentives, compliance rates, specific Sites/settings involved in the study, and other contextual issues Overall
22
• 
